Thomas Stranzl
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
-
- Allergic Rhinitis and Sensitization 5
-
- Acute Myeloid Leukemia Research 3
- Co-authors
- Mette Voldby LarsenClaus LundegaardMorten NielsenKarl MechtlerMartin FilipitsRobert PirkerGudrun PohlPeter Pichler
- Journals
- Advances in experimental medicine and biology (2 papers)Journal of Proteome Research (2 papers)Leukemia (2 papers)Breast Cancer Research and Treatment (2 papers)Blood (2 papers)
- Partner nations
- AustriaDenmarkUnited States
In The Last Decade
Thomas Stranzl
26 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 99
- Hematology 231
- Oncology 436
- Genetics 166
- Spectroscopy 233
- Molecular Biology 886
Countries citing papers authored by Thomas Stranzl
This map shows the geographic impact of Thomas Stranzl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Stranzl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Stranzl more than expected).
Fields of papers citing papers by Thomas Stranzl
This network shows the impact of papers produced by Thomas Stranzl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Stranzl. The network helps show where Thomas Stranzl may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Stranzl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 7 | |
| 4 | 2019 | 56 | |
| 5 | 2018 | 50 | |
| 6 | 2013 | 35 | |
| 7 | 2012 | 14 | |
| 8 | 2010 | 285 | |
| 9 | 2008 | 228 | |
| 10 | 2003 | 62 | |
| 11 | 2003 | 48 | |
| 12 | Expression of folylpolyglutamyl synthetase predicts poor response to methotrexate therapy in patients with rheumatoid arthritis. | 2003 | 19 |
| 13 | Expression of the lung resistance protein in primary colorectal carcinomas. | 2001 | 3 |
| 14 | Expression of the lung resistance protein (LRP) in primary breast cancer. | 2000 | 18 |
| 15 | Expression of the multidrug resistance protein (MRP1) in breast cancer. | 2000 | 26 |
| 16 | 2000 | 47 | |
| 17 | Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma. | 1999 | 39 |
| 18 | 1999 | 14 | |
| 19 | 1999 | 26 | |
| 20 | 1998 | 90 |
About Thomas Stranzl
Thomas Stranzl is a scholar working on Immunology and Allergy, Hematology, Genetics, Oncology and Spectroscopy, having authored 26 papers that have together received 1.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Allergic Rhinitis and Sensitization (5 papers), Asthma and respiratory diseases (4 papers), Cancer-related Molecular Pathways (4 papers), Mass Spectrometry Techniques and Applications (4 papers), Hemoglobinopathies and Related Disorders (3 papers), Acute Myeloid Leukemia Research (3 papers) and Respiratory and Cough-Related Research (3 papers). The work is most often cited by research in Hematology (231 citations), Oncology (436 citations), Genetics (166 citations), Spectroscopy (233 citations) and Molecular Biology (886 citations). Thomas Stranzl has collaborated with scholars based in Austria, Denmark and United States. Frequent co-authors include Mette Voldby Larsen, Claus Lundegaard, Morten Nielsen, Karl Mechtler, Martin Filipits, Robert Pirker, Gudrun Pohl, Peter Pichler, Viktoria Dorfer and Stephan Winkler. Their work appears in journals such as Advances in experimental medicine and biology, Journal of Proteome Research, Leukemia, Breast Cancer Research and Treatment and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.